Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

citation_title=Poly (ADP-Ribose) polymerase inhibitors: recent advances and future development; citation_author=Scott CL; citation_author=Swisher EM; citation_author=Kaufmann SH; citation_journal_title=J Clin Oncol; citation_year=2015; citation_volume=33; citation_pages=1397-406; citation_title=DNA repair dysregulation from cancer driver to therapeutic target; citation_author=Curtin NJ; citation_journal_title=Nat Rev Cancer; citation_year=2012; citation_volume=12; citation_pages=801-17; citation_title=Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer; citation_author=Konstantinopoulos PA; citation_author=Ceccaldi R; citation_author=Shapiro GI; citation_author=D'Andrea AD; citation_journal_title=Cancer Discov; citation_year=2015; citation_volume=5; citation_pages=1137-54; citation_title=Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action; citation_author=Pommier Y; citation_author=O'Connor MJ; citation_author=De Bono J; citation_journal_title=Sci Transl Med; citation_year=2016; citation_volume=8; citation_pages=362ps17 citation_title=PARP inhibitors: synthetic lethality in the clinic; citation_author=Lord CJ; citation_author=Ashworth A; citation_journal_title=Science; citation_year=2017; citation_volume=355; citation_pages=1152-8; citation_title=BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group; citation_author=Alsop K; citation_author=Fereday S; citation_author=Meldrum C; citation_author=deFazio A; citation_author=Emmanuel C; citation_author=George J; citation_journal_title=J Clin Oncol; citation_year=2012; citation_volume=30; citation_pages=2654-63; citation_title=Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial; citation_author=Ledermann J; citation_author=Harter P; citation_author=Gourley C; citation_author=Friedlander M; citation_author=Vergote I; citation_author=Rustin G; citation_journal_title=Lancet Oncol; citation_year=2014; citation_volume=15; citation_pages=852-61; citation_title=Niraparib maintenance therapy in platinum-sensitive, recurrent ovarian cancer; citation_author=Mirza MR; citation_author=Monk BJ; citation_author=Herrstedt J; citation_author=Oza AM; citation_author=Mahner S; citation_author=Redondo A; citation_journal_title=N Engl J Med; citation_year=2016; citation_volume=375; citation_pages=2154-64; citation_title=Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial; citation_author=Swisher EM; citation_author=Lin KK; citation_author=Oza AM; citation_author=Scott CL; citation_author=Giordano H; citation_author=Sun J; citation_journal_title=Lancet Oncol; citation_year=2017; citation_volume=18; citation_pages=75-87; citation_title=Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers; citation_author=Sakai W; citation_author=Swisher EM; citation_author=Karlan BY; citation_author=Agarwal MK; citation_author=Higgins J; citation_author=Friedman C; citation_journal_title=Nature; citation_year=2008; citation_volume=451; citation_pages=1116-20; citation_title=Resistance to therapy caused by intragenic deletion in BRCA2; citation_author=Edwards SL; citation_author=Brough R; citation_author=Lord CJ; citation_author=Natrajan R; citation_author=Vatcheva R; citation_author=Levine DA; citation_journal_title=Nature; citation_year=2008; citation_volume=451; citation_pages=1111-5; citation_title=Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas; citation_author=Norquist B; citation_author=Wurz KA; citation_author=Pennil CC; citation_author=Garcia R; citation_author=Gross J; citation_author=Sakai W; citation_journal_title=J Clin Oncol; citation_year=2011; citation_volume=29; citation_pages=3008-15; citation_title=Biomarkers of response and resistance to DNA repair targeted therapies; citation_author=Stover EH; citation_author=Konstantinopoulos PA; citation_author=Matulonis UA; citation_author=Swisher EM; citation_journal_title=Clin Cancer Res; citation_year=2016; citation_volume=22; citation_pages=5651-60; citation_title=Whole-genome characterization of chemoresistant ovarian cancer; citation_author=Patch A-M; citation_author=Christie EL; citation_author=Etemadmoghadam D; citation_author=Garsed DW; citation_author=George J; citation_author=Fereday S; citation_journal_title=Nature; citation_year=2015; citation_volume=521; citation_pages=489-94; citation_title=Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor; citation_author=Barber LJ; citation_author=Sandhu S; citation_author=Chen L; citation_author=Campbell J; citation_author=Kozarewa I; citation_author=Fenwick K; citation_journal_title=J Pathol; citation_year=2013; citation_volume=229; citation_pages=422-9; citation_title=Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas; citation_author=Pennington KP; citation_author=Walsh T; citation_author=Harrell MI; citation_author=Lee MK; citation_author=Pennil CC; citation_author=Rendi MH; citation_journal_title=Clin Cancer Res; citation_year=2014; citation_volume=20; citation_pages=764-75; citation_title=Integrated genomic analyses of ovarian carcinoma; citation_author=Cancer Genome Atlas Research Network; citation_journal_title=Nature; citation_year=2011; citation_volume=474; citation_pages=609-15; citation_title=Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition; citation_author=McCabe N; citation_author=Turner NC; citation_author=Lord CJ; citation_author=Kluzek K; citation_author=Bialkowska A; citation_author=Swift S; citation_journal_title=Cancer Res; citation_year=2006; citation_volume=66; citation_pages=8109-15; citation_title=Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing; citation_author=Frampton GM; citation_author=Fichtenholtz A; citation_author=Otto GA; citation_author=Wang K; citation_author=Downing SR; citation_author=He J; citation_journal_title=Nat Biotechnol; citation_year=2013; citation_volume=31; citation_pages=1023-31; citation_title=Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population; citation_author=Song H; citation_author=Dicks E; citation_author=Ramus SJ; citation_author=Tyrer JP; citation_author=Intermaggio MP; citation_author=Hayward J; citation_journal_title=J Clin Oncol; citation_year=2015; citation_volume=33; citation_pages=2901-7; citation_title=Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins; citation_author=Prakash R; citation_author=Zhang Y; citation_author=Feng W; citation_author=Jasin M; citation_journal_title=Cold Spring Harb Perspect Biol; citation_year=2015; citation_volume=7; citation_pages=a016600 citation_title=Inherited mutations in women with ovarian carcinoma; citation_author=Norquist BM; citation_author=Harrell MI; citation_author=Brady MF; citation_author=Walsh T; citation_author=Lee MK; citation_author=Gulsuner S; citation_journal_title=JAMA Oncol; citation_year=2016; citation_volume=2; citation_pages=482-90; citation_title=Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene; citation_author=Meindl A; citation_author=Hellebrand H; citation_author=Wiek C; citation_author=Erven V; citation_author=Wappenschmidt B; citation_author=Niederacher D; citation_journal_title=Nat Genet; citation_year=2010; citation_volume=42; citation_pages=410-4; citation_title=Germline mutations in RAD51D confer susceptibility to ovarian cancer; citation_author=Loveday C; citation_author=Turnbull C; citation_author=Ramsay E; citation_author=Hughes D; citation_author=Ruark E; citation_author=Frankum JR; citation_journal_title=Nat Genet; citation_year=2011; citation_volume=43; citation_pages=879-82; citation_title=Ovarian cancer-associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors; citation_author=Joshi PM; citation_author=Sutor SL; citation_author=Huntoon CJ; citation_author=Karnitz LM; citation_journal_title=J Biol Chem; citation_year=2014; citation_volume=289; citation_pages=9247-53; citation_title=Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex; citation_author=Ekumi KM; citation_author=Paculova H; citation_author=Lenasi T; citation_author=Pospichalova V; citation_author=Bosken CA; citation_author=Rybarikova J; citation_journal_title=Nucleic Acids Res; citation_year=2015; citation_volume=43; citation_pages=2575-89; citation_title=RNA-based analysis of BRCA1 and BRCA2 gene alterations; citation_author=Bonatti F; citation_author=Pepe C; citation_author=Tancredi M; citation_author=Lombardi G; citation_author=Aretini P; citation_author=Sensi E; citation_journal_title=Cancer Genet Cytogenet; citation_year=2006; citation_volume=170; citation_pages=93-101; citation_title=The BRCA1- 11q alternative splice isoform bypasses germline mutations and promotes therapeutic resistance to PARP inhibition and cisplatin; citation_author=Wang Y; citation_author=Bernhardy AJ; citation_author=Cruz C; citation_author=Krais JJ; citation_author=Nacson J; citation_author=Nicolas E; citation_journal_title=Cancer Res; citation_year=2016; citation_volume=76; citation_pages=2778-90; citation_title=Repression of mutagenesis by Rad51D-mediated homologous recombination; citation_author=Hinz JM; citation_author=Tebbs RS; citation_author=Wilson PF; citation_author=Nham PB; citation_author=Salazar EP; citation_author=Nagasawa H; citation_journal_title=Nucleic Acids Res; citation_year=2006; citation_volume=34; citation_pages=1358-68; citation_title=An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo; citation_author=Aubrey BJ; citation_author=Kelly GL; citation_author=Kueh AJ; citation_author=Brennan MS; citation_author=O'Connor L; citation_author=Milla L; citation_journal_title=Cell Reports.; citation_year=2015; citation_volume=10; citation_pages=1422-32; citation_title=XRCC3 promotes homology-directed repair of DNA damage in mammalian cells; citation_author=Pierce AJ; citation_author=Johnson RD; citation_author=Thompson LH; citation_author=Jasin M; citation_journal_title=Genes Dev; citation_year=1999; citation_volume=13; citation_pages=2633-8; citation_title=hSWS1•SWSAP1 is an evolutionarily conserved complex required for efficient homologous recombination repair; citation_author=Liu T; citation_author=Wan L; citation_author=Wu Y; citation_author=Chen J; citation_author=Huang J; citation_journal_title=J Biol Chem; citation_year=2011; citation_volume=286; citation_pages=41758-66; citation_title=Evidence for simultaneous protein interactions between human Rad51 paralogs; citation_author=Schild D; citation_author=Lio YC; citation_author=Collins DW; citation_author=Tsomondo T; citation_author=Chen DJ; citation_journal_title=J Biol Chem; citation_year=2000; citation_volume=275; citation_pages=16443-9; citation_title=Evolutionary and functional analysis of the invariant SWIM domain in the conserved Shu2/SWS1 protein family from Saccharomyces cerevisiae to Homo sapiens; citation_author=Godin SK; citation_author=Meslin C; citation_author=Kabbinavar F; citation_author=Bratton-Palmer DS; citation_author=Hornack C; citation_author=Mihalevic MJ; citation_journal_title=Genetics; citation_year=2015; citation_volume=199; citation_pages=1023-33; citation_title=Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts; citation_author=Topp MD; citation_author=Hartley L; citation_author=Cook M; citation_author=Heong V; citation_author=Boehm E; citation_author=McShane L; citation_journal_title=Mol Oncol; citation_year=2014; citation_volume=8; citation_pages=656-68; citation_title=Integrative genomics viewer; citation_author=Robinson JT; citation_author=Thorvaldsdottir H; citation_author=Winckler W; citation_author=Guttman M; citation_author=Lander ES; citation_author=Getz G; citation_journal_title=Nat Biotechnol; citation_year=2011; citation_volume=29; citation_pages=24-6; citation_title=Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing; citation_author=Walsh T; citation_author=Casadei S; citation_author=Lee MK; citation_author=Pennil CC; citation_author=Nord AS; citation_author=Thornton AM; citation_journal_title=Proc Natl Acad Sci; citation_year=2011; citation_volume=108; citation_pages=18032-7; citation_title=Fast gapped-read alignment with Bowtie 2; citation_author=Langmead B; citation_author=Salzberg SL; citation_journal_title=Nat Methods; citation_year=2012; citation_volume=9; citation_pages=357-9; citation_title=Trimmomatic: a flexible trimmer for Illumina sequence data; citation_author=Bolger AM; citation_author=Lohse M; citation_author=Usadel B; citation_journal_title=Bioinformatics; citation_year=2014; citation_volume=30; citation_pages=2114-20; citation_title=Xenomapper: mapping reads in a mixed species context; citation_author=Wakefield MJ; citation_journal_title=JOSS; citation_year=2016; citation_volume=1; citation_pages=18 citation_title=The sequence alignment/map format and SAMtools; citation_author=Li H; citation_author=Handsaker B; citation_author=Wysoker A; citation_author=Fennell T; citation_author=Ruan J; citation_author=Homer N; citation_journal_title=Bioinformatics; citation_year=2009; citation_volume=25; citation_pages=2078-9; citation_title=Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer; citation_author=Ha G; citation_author=Roth A; citation_author=Lai D; citation_author=Bashashati A; citation_author=Ding J; citation_author=Goya R; citation_journal_title=Genome Res; citation_year=2012; citation_volume=22; citation_pages=1995-2007; citation_title=Circos: an information aesthetic for comparative genomics; citation_author=Krzywinski M; citation_author=Schein J; citation_author=Birol I; citation_author=Connors J; citation_author=Gascoyne R; citation_author=Horsman D; citation_journal_title=Genome Research; citation_year=2009; citation_volume=19; citation_pages=1639-45; citation_title=Scalable molecular dynamics with NAMD; citation_author=Phillips JC; citation_author=Braun R; citation_author=Wang W; citation_author=Gumbart J; citation_author=Tajkhorshid E; citation_author=Villa E; citation_journal_title=J Comput Chem; citation_year=2005; citation_volume=26; citation_pages=1781-802; citation_title=Protein structure homology modeling using SWISS-MODEL workspace; citation_author=Bordoli L; citation_author=Kiefer F; citation_author=Arnold K; citation_author=Benkert P; citation_author=Battey J; citation_author=Schwede T; citation_journal_title=Nat Protocols; citation_year=2009; citation_volume=4; citation_pages=1-13; citation_title=Crystal structure of a Rad51 filament; citation_author=Conway AB; citation_author=Lynch TW; citation_author=Zhang Y; citation_author=Fortin GS; citation_author=Fung CW; citation_author=Symington LS; citation_journal_title=Nat Struct Mol Biol; citation_year=2004; citation_volume=11; citation_pages=791-6; citation_title=VMD: visual molecular dynamics; citation_author=Humphrey W; citation_author=Dalke A; citation_author=Schulten K; citation_journal_title=J Mol Graph; citation_year=1996; citation_volume=14;